Today: 14 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY shares jumped over 6% Thursday, trading near $63.70 after the company posted Q3 2025 results, raised its dividend, and issued stronger revenue guidance. Net revenue rose 6.4% sequentially to $540.2 million, though still down from last year. Trading volume topped 1.2 million shares. JOYY stock is up more than 50% year-to-date and near its 52-week high.
Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax shares surged 8% to $121.94 Thursday afternoon on heavy volume after fresh takeover rumors involving AstraZeneca. The French biotech’s stock is up about 1,450% year-to-date, fueled by strong Phase 3 ulcerative colitis data and M&A speculation. No deal has been confirmed by either company. Intraday volume reached 3.75 million ADSs, far above recent averages.
20 November 2025
Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

KLIC shares jumped 11% to around $39.23 Thursday after Kulicke & Soffa posted better-than-expected Q4 earnings and raised its outlook for early fiscal 2026. Volume neared 900,000 shares by early afternoon. Q4 revenue reached $177.6 million, down 2% year over year but up 20% sequentially. The move follows a 12% after-hours surge Wednesday after the company beat Wall Street estimates.
20 November 2025
1 702 703 704

Stock Market Today

  • Cadre Holdings (CDRE) Shares Drop 27% in a Week - Potential Undervaluation Signals
    March 13, 2026, 11:01 PM EDT. Cadre Holdings (CDRE) saw its share price plunge 27.3% over the past week, extending a 23% year-to-date decline amid volatile trading. Despite this, a Discounted Cash Flow analysis estimates an intrinsic value of $57.23 versus the recent $31.65 share price, indicating the stock could be undervalued by nearly 45%. Cadre, a supplier of safety equipment to law enforcement, has generated $56.6 million in free cash flow over the last twelve months. Analysts forecast growth pushing cash flow to $162.8 million by 2035. The company's valuation score stands at 5 out of 6 on Simply Wall St, suggesting caution but opportunity for investors amid the recent price slump and mixed peer performance.
Go toTop